Santosh Laxman Parab
About Santosh Laxman Parab
Data last updated:
Santosh Laxman Parab is a Cfo at Camlin Fine Sciences Limited (since 2017) and Director at Bliss Gvs Pharma Limited (since 2016). The companies operate in Chemicals and Materials, Pharma and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹2,527 Cr; the largest is Camlin Fine Sciences Limited at ₹1,681 Cr (FY 2025). Earlier, Santosh Laxman Parab was a Director at Maha Arc Limited (2022–2025) and Nominee Director at Sapling Agrotech Private Limited (2006–2012) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Camlin Fine Sciences Limited L74100MH1993PLC075361 | Cfo | 10 Feb 2017 | 1993 | ₹1,681 Cr (FY 2025) | Active |
 Bliss Gvs Pharma Limited L24230MH1984PLC034771 | Director | 24 May 2016 | 1984 | ₹846 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Maha Arc Limited U67190MH2022SGC391104 | Director | 18 Nov 2022 | 2022 | ₹19.36 Cr (FY 2025) | Active |
| Sapling Agrotech Private Limited U01409WB1997PTC084709 | Nominee Director | 01 Sep 2006 | 1997 | Active | |
 Richa Space Private Limited U45206MH2013PTC247980 | Director | 18 Mar 2015 | 2013 | Active | |
| Transformiti Research Solutions Private Limited U73100MH2015PTC261169 | Director | 20 Jan 2015 | 2015 | ₹5 Lakh (FY 2016) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Santosh Laxman Parab
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Santosh Laxman Parab
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Santosh Laxman Parab
Santosh Laxman Parab currently holds 2 directorships: Camlin Fine Sciences Limited (Cfo, since 10 Feb 2017, revenue ₹1,681 Cr (FY 2025)); Bliss Gvs Pharma Limited (Director, since 24 May 2016, revenue ₹846 Cr (FY 2025)).
Santosh Laxman Parab was first appointed on 01 Sep 2006 as Nominee Director at Sapling Agrotech Private Limited. The most recent appointment on record is 18 Nov 2022 at Maha Arc Limited.
The 2 current companies of Santosh Laxman Parab that report revenue have a combined latest revenue of ₹2,527 Cr: Camlin Fine Sciences Limited ₹1,681 Cr (FY 2025); Bliss Gvs Pharma Limited ₹846 Cr (FY 2025).
Santosh Laxman Parab held 4 earlier board appointments: Maha Arc Limited (Director, 18 Nov 2022 to 17 Nov 2025); Sapling Agrotech Private Limited (Nominee Director, 01 Sep 2006 to 31 Mar 2012); Richa Space Private Limited (Director, 18 Mar 2015 to 30 Sep 2015); Transformiti Research Solutions Private Limited (Director, 20 Jan 2015 to 02 May 2022).
The current boards of Santosh Laxman Parab's companies include Abeezar Ebrahim Faizullabhoy (Camlin Fine Sciences Limited), Amol Jashvant Shah (Camlin Fine Sciences Limited), Anagha Subhash Dandekar (Camlin Fine Sciences Limited), Arjun Sudhakar Dukane (Camlin Fine Sciences Limited), Ashish Subhash Dandekar (Camlin Fine Sciences Limited), Harsha Raghavan (Camlin Fine Sciences Limited), among others.